secwatch.observer — SEC 8-K summary
======================================

Issuer:     X4 Pharmaceuticals, Inc (XFOR)
CIK:        0001501697
Form:       8-K
Filed at:   2023-11-14T23:59:59+00:00
Accession:  0001628280-23-038936
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

X4 Pharmaceuticals receives Nasdaq deficiency notice for bid price below $1.00
------------------------------------------------------------------------------

- Received Nasdaq letter on Nov 13, 2023 for non-compliance with minimum $1.00 bid price rule.
- Common stock closing bid price below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until May 13, 2024, to regain compliance.
- If not compliant by deadline, may request additional 180 days if other listing standards are met.
- Considering potential reverse stock split to cure deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501697/000162828023038936/0001628280-23-038936-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501697/000162828023038936/xfor-20231113.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-038936

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer